These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10898828)

  • 1. Tazarotene combination treatments in psoriasis.
    Guenther L
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S36-42. PubMed ID: 10898828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing treatment with topical tazarotene.
    Guenther LC
    Am J Clin Dermatol; 2003; 4(3):197-202. PubMed ID: 12627995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid.
    Lebwohl M
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S43-6. PubMed ID: 10898829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies.
    Endzweig-Gribetz CH; Brady C; Lynde C; Sibbald D; Lebwohl M
    J Cutan Med Surg; 2002; 6(3 Suppl):12-6. PubMed ID: 11976987
    [No Abstract]   [Full Text] [Related]  

  • 5. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
    Lebwohl MG; Breneman DL; Goffe BS; Grossman JR; Ling MR; Milbauer J; Pincus SH; Sibbald RG; Swinyer LJ; Weinstein GD; Lew-Kaya DA; Lue JC; Gibson JR; Sefton J
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):590-6. PubMed ID: 9777766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
    Green L; Sadoff W
    J Cutan Med Surg; 2002; 6(2):95-102. PubMed ID: 11992180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
    Poulin YP
    Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study.
    Bowman PH; Maloney JE; Koo JY
    J Am Acad Dermatol; 2002 Jun; 46(6):907-13. PubMed ID: 12063489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis: current perspectives with an emphasis on treatment.
    Linden KG; Weinstein GD
    Am J Med; 1999 Dec; 107(6):595-605. PubMed ID: 10625029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and safety of tazarotene: optimizing clinical results.
    Lebwohl M
    Cutis; 1998 Feb; 61(2 Suppl):27-9. PubMed ID: 9787989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instrumental evaluation of retinoid-induced skin irritation.
    Stücker M; Hoffmann M; Altmeyer P
    Skin Res Technol; 2002 May; 8(2):133-40. PubMed ID: 12060479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel.
    Behrens S; Grundmann-Kollmann M; Schiener R; Peter RU; Kerscher M
    J Am Acad Dermatol; 2000 Mar; 42(3):493-5. PubMed ID: 10688723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Topical treatments for psoriasis in 2009].
    Thielen AM; Laffitte E
    Rev Med Suisse; 2009 Apr; 5(200):876, 878-81. PubMed ID: 19438087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical agents for the treatment of psoriasis, past, present and future.
    Tremblay JF; Bissonnette R
    J Cutan Med Surg; 2002; 6(3 Suppl):8-11. PubMed ID: 11976984
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of tazarotene and acitretin in psoriasis.
    Heath MS; Sahni DR; Curry ZA; Feldman SR
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis.
    Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
    Br J Dermatol; 2000 Dec; 143(6):1275-8. PubMed ID: 11122033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.
    Tzaneva S; Hönigsmann H; Tanew A; Seeber A
    Br J Dermatol; 2002 Oct; 147(4):748-53. PubMed ID: 12366423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tazarotene in combination with topical corticosteroids.
    Lebwohl M; Poulin Y
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S139-43. PubMed ID: 9777792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical antipsoriatics.
    Smith KC; Lebwohl M
    Skin Therapy Lett; 2000; 5(2):1-2. PubMed ID: 10751842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis.
    Gollnick H; Menter A
    Br J Dermatol; 1999 Apr; 140 Suppl 54():18-23. PubMed ID: 10731130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.